Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Illumina (ILMN-1.73%) is the industry leader in using short-read sequencing technology, which breaks DNA into short segments to aid in analysis for genetic research, testing, and medical treatment.